Evidence map›Paper›PMID 29963130›Full record

ArticleOncology letters2018

Camptothecin inhibits the progression of NPC by regulating TGF-β-induced activation of the PI3K/AKT signaling pathway.

Ben-Shan Li, Ji-Yi Huang, Jing Guan, Long-Hua Chen

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ben-Shan LiDepartment of Radiation Oncology, Nanfang Hospital Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Ji-Yi HuangDepartment of E.N.T., People's Hospital of Jiangmen, Jiangmen, Guangdong 529000, P.R. China.
Jing GuanDepartment of Oncology, People's Hospital of Jiangmen, Jiangmen, Guangdong 529000, P.R. China.
Long-Hua ChenDepartment of Radiation Oncology, Nanfang Hospital Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Jiangmen Central Hospital · CNNanfang Hospital · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nasopharyngeal carcinoma (NPC) is a type of cancer that is characterized by increased invasiveness, metastatic potential and tumor recurrence. Camptothecin has been demonstrated to exhibit anticancer activity. However, the potential underlying molecular mechanisms mediated by camptothecin in NPC cells remain elusive. In the present study, the efficacy of camptothecin for NPC was investigated

Indexed as

camptothecinnasopharyngeal carcinomaphosphoinositide 3-kinase/protein kinase Btransforming growth factor-β

Identifiers

PMID29963130
PMCPMC6019887
OpenAlexW2802982618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.